China SXT Pharmaceuticals (SXTC) Current Deferred Revenue (2018 - 2026)
China SXT Pharmaceuticals' Current Deferred Revenue came in at $104,423 for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 78.1% from $58,627 a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Current Deferred Revenue (2018 - 2026) Analysis & Trends
Going back to fiscal Q4 2018, China SXT Pharmaceuticals' Current Deferred Revenue data covers 17 quarters.
- Current Deferred Revenue carries a five-year compound annual growth rate of -16.5% (FY2021 to FY2026).
- Going back by fiscal year, Current Deferred Revenue was $58,627 in FY2025 (-68.8%), $187,665 in FY2024 (+13.4%), $165,534 in FY2023 (+114.0%) and $77,366 in FY2022 (-69.9%).
- The fiscal Q4 2026 figure represents the highest quarterly Current Deferred Revenue since fiscal Q2 2025.
- Year-over-year, Current Deferred Revenue increased in two of the last four quarters, with an average decline of 14.1%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in fiscal Q2 2024 (growth of 192.2%), and the weakest in fiscal Q2 2023 (a decline of 70.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | China SXT Pharmaceuticals | 36,875.63 | -85.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 104,423.00 |
| Sep 30, 2025 | 65,057.00 |
| Mar 31, 2025 | 58,627.00 |
| Sep 30, 2024 | 190,340.00 |
| Mar 31, 2024 | 187,665.00 |
| Sep 30, 2023 | 190,193.00 |
| Mar 31, 2023 | 165,534.00 |
| Sep 30, 2022 | 65,101.00 |
| Mar 31, 2022 | 77,366.00 |
| Sep 30, 2021 | 218,644.00 |
| Mar 31, 2021 | 257,449.00 |
| Sep 30, 2020 | 217,412.00 |
| Mar 31, 2020 | 298,042.00 |
| Sep 30, 2019 | 120,575.00 |
| Mar 31, 2019 | 57,553.00 |
| Sep 30, 2018 | 117,992.00 |
| Mar 31, 2018 | 292,947.00 |
API Access
China SXT Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();